No securities are beneficially owned.
The reporting person is a member of and holds a non-controlling interest in Aesther Healthcare Sponsor, LLC (the "Sponsor"), which beneficially owns 2,875,000 shares of Class B common stock of Issuer, including an aggregate of up to 375,000 shares subject to forfeiture by the Sponsor to the extent that the underwriter's over-allotment is not exercised in full or in part (provided that a portion of such over-allotment has already been exercised and as such only 250,000 shares remain subject to forfeiture). The Sponsor is controlled by its sole manager, Suren Ajjarapu, the Chief Executive Officer of the Issuer.